526PPHASE II STUDY OF COMBINED CHEMOTHERAPY WITH 5-WEEK CYCLES OF S-1 AND CPT-11 (IRIS) PLUS BEVACIZUMAB IN PATIENTS WITH METASTATIC COLON CANCER

Abstract Aim: Combined chemotherapy with S-1 and irinotecan (IRIS) for metastatic colorectal cancer has been reported to be effective and safe. However, there are only a few studies on the effects of adding bevacizumab to the IRIS. We conducted a clinical study to evaluate the efficacy and safety of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2014-09, Vol.25 (suppl_4), p.iv179-iv179
Hauptverfasser: Mizushima, T., Ide, Y., Murata, K., Ohashi, I., Yasumasa, K., Fukunaga, M., Takemoto, H., Tamagawa, H., Kato, T., Ikenaga, M., Hasegawa, J., Hata, T., Takemasa, I., Ikeda, M., Satoh, T., Yamamoto, H., Sekimoto, M., Nezu, R., Doki, Y., Mori, M.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!